Showing results (31-40 of 91) with videos related to
Sort By:
Pageof 10
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
Controversies in the management of gastrointestinal stromal tumorsDesmond Yip, John Zalcberg, Stephen Ackland, et al.Oncogene|February 27, 2004
Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitorAlyssa M Morimoto, Nguyen Tan, Kristina West, et al.BMC Medical Education|July 31, 2023
Designing a wholly online, multidisciplinary Master of Cancer Sciences degreeJulia Lai-Kwon, Sathana Dushyanthen, David Seignior, et al.European Journal of Cancer (Oxford, England : 1990)|November 16, 2018
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEmma L Mitchell, Peter Kar Han Lau, Chloe Khoo, et al.Oncoimmunology|April 23, 2021
Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538Oliver Klein, Clare Senko, Matteo S Carlino, et al.Asia-Pacific Journal of Clinical Oncology|February 10, 2021
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemicKoen Degeling, Nancy N Baxter, Jon Emery, et al.Asia-Pacific Journal of Clinical Oncology|December 2, 2016
Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologistsVictoria Atkinson, Georgina V Long, Alexander M Menzies, et al.Nature Reviews. Disease Primers|May 19, 2016
MelanomaDirk Schadendorf, David E Fisher, Claus Garbe, et al.JAMA Oncology|July 31, 2020
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical TrialOliver Klein, Damien Kee, Adnan Nagrial, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
c-Myb is required for progenitor cell homeostasis in colonic cryptsJordane Malaterre, Marina Carpinelli, Matthias Ernst, et al.Pageof 10